PDGFRA and Osteochondroma: (I–M) 0.735 mg/kg PVO-treated and (N–R) 1.47 mg/kg PVO-treated Pdgfrα-R206H mice exhibited reduced HO (arrows), and (J, O, P) osteochondromas were often absent (asterisks).